November 12, 2024CorporateTerumo Blood and Cell Technologies Merges Therapeutics Units to Enhance Patient Care Across Treatment JourneyNew Global Therapy Innovations business unit, led by Veerle d’Haenens, aims to unify therapeutic apheresis and cell and gene therapy expertise to expand therapeutic possibilities
November 07, 2024FinancialNotice Concerning Revisions to Full-Year Consolidated Financial Guidance for Fiscal Year Ending March 31, 2025 (FY2024) (PDF 85.27 KB)
November 14, 2023 Terumo India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections to Manage Diabetes April 24, 2023 Terumo Group’s Targets for Greenhouse Gas Reduction Approved by the SBT Initiative as 1.5°C Aligned February 09, 2023 Terumo to Revise Performance Evaluation System for Executive Officers January 26, 2023 Terumo Group to Establish the Sustainability Committee March 02, 2022 Terumo Selected for a Major ESG Investment Index 'MSCI Japan ESG Select Leaders Index' for the First Time June 16, 2021 Terumo Selected for the Global ESG Investment Index 'FTSE4Good Index Series' and 'FTSE Blossom Japan Index' May 14, 2021 Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHO Contributions will Help Bolster Vaccine Equity April 22, 2020 Terumo Donates USD 2.4 Million in Cash and Products to Support COVID-19 Pandemic Relief Efforts Worldwide Contributions include USD 1 million to the COVID-19 Solidarity Response Fund for WHO March 26, 2020 Terumo Group Greenhouse Gas Reduction Target Approved by the SBTi To Mitigate Climate Change Risks by Science-based Approach February 04, 2020 Terumo Responds to the Novel Coronavirus Outbreak in China December 19, 2019 Terumo Supports Gender Diversity and a Culture of Inclusion and Belonging December 10, 2019 Terumo Establishes "Terumo Group Human Rights Policy" To be a Socially Trusted Company, and to Achieve a Sustainable Society September 25, 2019 The Organization of African First Ladies for Development (OAFLAD) and Terumo BCT Panel: The Importance of Blood for Africa's Mothers Today on the sidelines of the 74th session of the United Nations General Assembly September 23, 2019 Terumo BCT Offers $100,000 Research Grant Supporting Patient Access to Care Therapeutic Plasma Exchange Innovation Award Aims to Promote Data-Driven Research in Neurology and Nephrology Fields Pagination Previous page ‹ Current page1 Next page ›
November 14, 2023 Terumo India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections to Manage Diabetes
April 24, 2023 Terumo Group’s Targets for Greenhouse Gas Reduction Approved by the SBT Initiative as 1.5°C Aligned
March 02, 2022 Terumo Selected for a Major ESG Investment Index 'MSCI Japan ESG Select Leaders Index' for the First Time
June 16, 2021 Terumo Selected for the Global ESG Investment Index 'FTSE4Good Index Series' and 'FTSE Blossom Japan Index'
May 14, 2021 Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHO Contributions will Help Bolster Vaccine Equity
April 22, 2020 Terumo Donates USD 2.4 Million in Cash and Products to Support COVID-19 Pandemic Relief Efforts Worldwide Contributions include USD 1 million to the COVID-19 Solidarity Response Fund for WHO
March 26, 2020 Terumo Group Greenhouse Gas Reduction Target Approved by the SBTi To Mitigate Climate Change Risks by Science-based Approach
December 10, 2019 Terumo Establishes "Terumo Group Human Rights Policy" To be a Socially Trusted Company, and to Achieve a Sustainable Society
September 25, 2019 The Organization of African First Ladies for Development (OAFLAD) and Terumo BCT Panel: The Importance of Blood for Africa's Mothers Today on the sidelines of the 74th session of the United Nations General Assembly
September 23, 2019 Terumo BCT Offers $100,000 Research Grant Supporting Patient Access to Care Therapeutic Plasma Exchange Innovation Award Aims to Promote Data-Driven Research in Neurology and Nephrology Fields
Top
Top